Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2001-07-30
Original market date: See footnote 1
1997-08-29
Product name:
SERENTIL TAB 25MG
DIN:
00027456 Electronic product monograph is not available
Company:
NOVARTIS PHARMACEUTICALS CANADA INC
100
700 Rue Saint-Hubert
Montreal
Quebec
Canada
H2Y 0C1
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
28:16.08.24
Anatomical Therapeutic Chemical (ATC): See footnote 4
N05AC03 MESORIDAZINE
Active ingredient group (AIG) number:See footnote5
0106196001
Active ingredient(s) See footnote8 | Strength |
---|---|
MESORIDAZINE (MESORIDAZINE BESYLATE) | 25 MG / TAB |